Trial Profile
Safety and efficacy of conbercept in management of severe proliferative diabetic retinopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions; Therapeutic Use
- 23 Feb 2017 New trial record